Aspire Biopharma Holdings, Inc. Common Stock

ASBPNASDAQ • USD
ThemeNanotech & Adv. Materials›Nanomedicine & Drug Delivery
6.04 USD
↗ 0.01 (0.17%)AT CLOSE (11:59 AM EDT)
6.10
↗ 0.06 (1.06%)
POST MARKET (AS OF 06:33 PM EDT)
Post Market
AS OF 06:33 PM EDT
6.10
↗ 0.06 (1.06%)
🔴Market: CLOSED

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is currently trading at $6.10. Our models show a "Neutral" technical signal alongside a "Neutral" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. ASBP is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jul 15, 2026.

Open?$6.03
High?$6.35
Low?$5.96
Prev. Close?$6.03
Volume?89.2K
Avg. Volume?539.0K
VWAP?$6.09
Rel. Volume?0.17x
Bid / Ask
Bid?$5.09 × 100
Ask?$7.10 × 100
Spread?$2.01
Midpoint?$6.10
Valuation & Ratios
Market Cap?7.8M
Shares Out?1.3M
Float?4.5M
Float %?89.7%
P/E Ratio?N/A
P/B Ratio?2.02
EPS?-$9.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Themes
Nanotechnology & Advanced Materials›Nanomedicine & Drug DeliveryBiotech - Drug Development›Clinical-Stage Platforms
Employees
N/A
Market Cap
7.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.aspirebiolabs.com
Listed
2025-02-20
Address
23150 FASHION DRIVE, SUITE 232
ESTERO, FL 33928
Phone: 561-704-8527
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
69
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.40Distress
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.25%Low
Short Interest?101.4K
Days to Cover?1.0
Free Float4.5M
Avg Daily Volume158.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.26Strong
Quick Ratio?2.14Strong
Cash Ratio?1.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
74
2.02CHEAP▾
P/S?
Peers
100
S&P
3
226.02HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
56.53HIGH▾
Returns & Efficiency
ROE?
S&P
3
-304.1%WEAK▾
ROA?
S&P
3
-165.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist